3
396
J. Bezenšek et al. / Tetrahedron Letters 51 (2010) 3392–3397
CO Me
MeOC
S
2
CO Me
2
CO Me
2
S
S
[1,3]
COMe
+
N
N
CO Me
2
COMe
N
CO Me
CO Me
2
2
1
2b
3
15
16
CO Me
CO Me
MeO C
MeO C
2
MeO C
2
2
2
2
CO Me
2
S
S
S
[
1,3]
Me
O
N
N
N
Me
O
O
1
7
18
13b
Scheme 4. The proposed mechanism for the formation of 13b.
3
.3. (E)-Dimethyl 6-[2-(dimethylamino)vinyl]-5-oxo-2,3,5,7a-
tetrahydropyrrolo[2,1-b]thiazole-7,7a-dicarboxylate (13a) and
2E,3E)-dimethyl 2-[2-(4,5-dihydrothiazol-2-yl)-2-
CH
3.88 (3H, s, COOMe); 4.29–4.40 (1H, m, 1H of thiazolidine CH
NMR (CDCl , 75.5 MHz): d 11.0, 36.9, 44.6, 52.5, 53.8, 78.3, 141.5,
143.0, 162.9, 168.5, 172.6. (C11 S requires: C, 48.70; H,
.83; N, 5.16; found C, 48.75; H, 4.66; N, 5.07); EI-HRMS: m/
2 2
); 3.48–3.57 (2H, m, CH of thiazolidine); 3.77 (3H, s, COOMe);
13
2
).
C
(
3
oxoethylidene]-3-[(dimethylamino)methylene]succinate (14)
H13NO
5
4
+
+
Prepared from (E)-1-(4,5-dihydrothiazol-2-yl)-3-(dimethyl-
amino)prop-2-en-1-one (12a) (276 mg, 1.5 mmol) and DMAD (3)
z = 272.0588 (MH ); C11
5
H14NO S requires: m/z = 272.0593 (MH );
m
max (KBr) 3008, 2959, 1734, 1706, 1464, 1438, 1347, 1326, 1278,
ꢁ
1
(
366
l
L, 3.0 mmol) in MeCN (1.5 mL), 60 °C, 10 min. The two prod-
1217, 1161, 1071, 990, 955, 925 cm .
ucts were separated by column chromatography (EtOAc/petroleum
ether = 1:2). Fractions containing the products were combined and
evaporated in vacuo.
3.7. X-ray structure analysis for compounds 2f, 4d, 13a and 13b
Single crystal X-ray diffraction data of compounds 2f, 4d, 13a
and 13b were collected at room temperature on a Nonius Kappa
3
.4. Major product 13a
14
CCD diffractometer using the Nonius Collect Software.
DENZO
1
5
Elutes first, recrystallized from EtOAc/petroleum ether. Yield:
56 mg (32%); yellow solid; mp 103–115 °C. H NMR (CDCl
and SCALEPACK were used for indexing and scaling of the data and
1
16
1
3
3
,
the structures were solved by means of SIR97. Refinement was
1
7
00 MHz): d 3.00 (6H, s, NMe
2
); 3.31–3.53 (3H, m, 3H of thiazoli-
performed using the XTAL3.4 program package and the crystallo-
1
8
dine); 3.72 (3H, s, COOMe); 3.80 (3H, s, COOMe); 4.29–4.36 (1H,
m, 1H of thiazolidine); 5.98 (1H, d, J = 13.2 Hz, CH); 8.49 (1H, d,
graphic plots were prepared by ORTEP III. Crystal structures were
refined on F values using the full-matrix least-squares procedure.
The non-hydrogen atoms were refined anisotropically in all cases,
while the positions of the hydrogen atoms were geometrically cal-
culated and their positional and isotropic atomic displacement
parameters were not refined. Absorption correction was not neces-
1
3
J = 13.2 Hz, CH). C NMR (CDCl
3.5, 79.0, 90.1, 120.4, 140.4, 150.9, 164.4, 169.6, 172.3.
S requires: C, 51.52; H, 5.56; N, 8.58; found C, 51.30;
3
, 75.5 MHz): d 36.0, 43.9, 51.4,
5
14 18 2 5
(C H N O
+
H, 5.56; N, 8.42); EI-HRMS: m/z = 327.1012 (MH ); C14
H
19
N
2
O
5
S re-
max (KBr) 2948, 1755, 1735, 1697,
611, 1565, 1431, 1406, 1341, 1251, 1191, 1162, 1109, 1040,
+
19
quires: m/z = 327.1015 (MH );
1
1
m
sary. Regina weighting scheme was used in all cases.
ꢁ1
Acknowledgements
011, 974, 861 cm
.
Financial support from the Slovenian Research Agency through
grants P0-0502-0103, P1-0179 and J1-6689-0103-04 is gratefully
acknowledged. We also thank the Krka d.d. (Novo mesto, Slovenia)
and Lek d.d., a Sandoz Company (Ljubljana, Slovenia) for financial
support.
3
.5. Minor product 14
Elutes second. Yield: 38 mg (8%); red oil. 1H NMR (CDCl
00 MHz): d 2.84 (6H, s, NMe ); 3.32 (2H, t, J = 8.7 Hz, CH of thia-
3
,
3
2
2
zolidine); 3.64 (3H, s, COOMe); 3.81 (3H, s, COOMe); 4.55 (2H, t,
J = 8.7 Hz, CH
C(2 )-H). C NMR (CDCl
0
2
of thiazolidine); 7.70 (1H, s, C(3 )-H); 7.89 (1H, s,
0
13
Supplementary data
3
, 75.5 MHz): d 32.9, 43.9, 51.6, 53.1,
6
6.4, 93.3, 120.7, 142.4, 155.5, 168.7, 169.1, 172.2, 181.0. EI-HRMS:
+
Crystallographic data (excluding structure factors) for the struc-
tures in this paper have been deposited with the Cambridge Crys-
tallographic Data Centre as supplementary publication numbers
CCDC 768092 (2f), 768093 (4d), 768094 (13a) and 768095(13b).
Copies of these data can be obtained, free of charge, on application
to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK [fax: +44(0)-
m/z = 327.1006 (MH );
C
14
19
H N
2
O
5
S
requires: m/z = 327.1015
+
(
MH );ax (KBr) 2949, 1723, 1692, 1604, 1538, 1433, 1400, 1328,
ꢁ1
1
255, 1217, 1135, 1089, 1046, 997, 942, 923 cm
.
3
.6. Dimethyl 6-methyl-5-oxo-2,3,5,7a-tetrahydropyrrolo[2,1-
b]thiazole-7,7a-dicarboxylate (13b)
1
223-336033 or e-mail: deposit@ccdc.cam.ac.uk. Supplementary
Prepared from 1-(4,5-dihydrothiazol-2-yl)ethanone (12b)
(
440 mg, 3.4 mmol) and DMAD (3) (830
lL, 6.8 mmol) in MeCN
(
3 mL), 60 °C, 15 min, column chromatography (EtOAc/petroleum
References and notes
ether = 1:3), recrystallized from EtOAc/petroleum ether. Yield:
1
3
1
71 mg (19%); white solid; mp 106–109 °C. H NMR (CDCl
3
,
1.
Trost, B. M., Fleming, I., Paquette, L. A., Eds.Comprehensive Organic Synthesis;
Oxford: Pergamon, 1991; Vol. 5,. Chapters 2.1–2.6.
00 MHz): d 2.19 (3H, s, CH ); 3.31–3.42 (1H, m, 1H of thiazolidine
3